Oncosil Medical Ltd has released a press release.
$5.3 million raised under Entitlement Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- 1st Study in Man Increases Pancreatic Tumor Vascularity
- First patient treated with OncoSil device in Turkiye
- First patient treated in the UK for the TRIPP-FXX study
- First Austria-based treatments utilising the OncoSil device
- Prospectus - Entitlement Offer
Later from OncoSil Medical
- Australian institution to invest $2.7 million in OSL
- Successful Treatment with OncoSil Device in Turkiye
- Appendix 4E Preliminary Financial Report
- G-BA Approval received for OncoSil Device
- OSL completes $7 M Placement and announces $1 M SPP
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical